Cite
Konishi Y, Sklavenitis-Pistofidis R, Yue H, et al. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2021;40(1):6-8doi: 10.1016/j.ccell.2021.12.003.
Konishi, Y., Sklavenitis-Pistofidis, R., Yue, H., Ferrari, F., Redd, R. A., Lightbody, E. D., Russo, M., Perry, J., Horowitz, E., Justis, A. V., Shayegh, N. A., Savell, A., Prescott, J., Varmeh, S., Nowak, R. P., Hamilton, M., Auclair, D., Marinac, C. R., Trippa, L., Fischer, E. S., & Ghobrial, I. M. (2022). Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer cell, 40(1), 6-8. https://doi.org/10.1016/j.ccell.2021.12.003
Konishi, Yoshinobu, et al. "Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia." Cancer cell vol. 40,1 (2022): 6-8. doi: https://doi.org/10.1016/j.ccell.2021.12.003
Konishi Y, Sklavenitis-Pistofidis R, Yue H, Ferrari F, Redd RA, Lightbody ED, Russo M, Perry J, Horowitz E, Justis AV, Shayegh NA, Savell A, Prescott J, Varmeh S, Nowak RP, Hamilton M, Auclair D, Marinac CR, Trippa L, Fischer ES, Ghobrial IM. Attenuated response to SARS-CoV-2 vaccine in patients with asymptomatic precursor stages of multiple myeloma and Waldenstrom macroglobulinemia. Cancer Cell. 2022 Jan 10;40(1):6-8. doi: 10.1016/j.ccell.2021.12.003. Epub 2021 Dec 09. PMID: 34895486; PMCID: PMC8654583.
Copy
Download .nbib
